Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Large Is the Neuroregeneration Therapy Market Expected to Be in 2029?
Over recent years, there has been a substantial increase in the market size for neuroregeneration therapies. The market is set to expand from $9.98 billion in 2024 to reach $11.29 billion in 2025, representing a compound annual growth rate (CAGR) of 13.1%. This significant growth during the historical period was caused by several factors, including a higher occurrence of neurological disorders, a surge in the global geriatric population, more investment in research and development, increased government support and funding, and thriving partnerships between academic institutions and industries.
The market size for neuroregeneration treatment is predicted to witness swift escalation in the coming years, expanding to $18.23 billion by 2029 with a 12.7% compound annual growth rate (CAGR). The spurt in the projected period can be tied to the surging demand for neuroregeneration treatments, escalated demand for cellular therapies, growing healthcare requirements, increased investment in biotechnology, and an aging population on the rise. Key trends anticipated during the forecast period comprise advancements in stem cell-centric therapies, the progression in personalized medicine, novel gene editing techniques for neurodegenerative conditions, utilization of nanotechnology in drug conveyance, and the progression in pharma-biotech.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27358&type=smp
What Are The Contributors To Demand In The Neuroregeneration Therapy Market?
The neuroregeneration therapy market is projected to grow significantly due to the increasing prevalence of neurological disorders. These disorders, which affect the brain, spinal cord or peripheral nerves, are often linked to environmental toxins boosting their incidence. As these toxins, including heavy metals, pesticides, and industrial chemicals, can damage the nervous system, they often lead to neurodegenerative diseases. Neurological disorders can be treated with neuroregeneration therapy, which repairs or replaces damaged neurons and tissues enhancing bodily functions and overall life quality. For instance, the World Federation of Neurology, a UK-based conglomerate of national neurological societies, reported in October 2023 that over 40% of the global population suffers from some neurological condition. This figure is anticipated to nearly double by 2050. This increase in prevalence of such disorders is fuelling the growth of the neuroregeneration therapy market. The neuroregeneration therapy market is also expected to grow substantially due to the increase in the aging population. The aging population describes a population trend where there is an increase in elderly individuals creating economic and social hurdles. This trend is primarily due to better healthcare and improved living standards. Neuroregeneration therapy is beneficial for the elderly as it helps in repair of damaged neurons, enhancing mobility, and slowing age-related cognitive decline. The House of Commons Library, a UK-based information hub of the British Parliament’s lower house, reported in July 2024 that in 2022, about 19% (nearly 12.7 million) of the UK’s total population was over the age of 65. This trend is projected to grow even more, reaching 22.1 million by 2072 representing 27% of the total population. Thus, the growing aging population is fuelling the growth of the neuroregeneration therapy market.
What Segmentation Categories Are Included In The Neuroregeneration Therapy Market Analysis?
The neuroregeneration therapy market covered in this report is segmented
1) By Type Of Neuroregeneration Therapy: Stem Cell Therapy, Gene Therapy, Pharmacological Therapy, Neurostimulation Therapy, Other Types Of Neuroregeneration Therapy
2) By Technology: Tissue Engineering, Cranial And Spinal Stimulation, Nanotechnology In Drug Delivery, Biomaterials Development
3) By Mode Of Administration: Oral, Injectable, Implantable, Other Modes Of Administration
4) By Indication: Spinal Cord Injury, Traumatic Brain Injury, Stroke, Parkinson’s Disease, Multiple Sclerosis, Alzheimer’s Disease, Peripheral Nerve Injury, Other Indications
5) By End-User: Hospitals, Clinical Research Institutes, Academic Institutions, Pharmaceutical And Biotechnology Companies
Subsegment:
1) By Stem Cell Therapy: Embryonic Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Neural Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, Hematopoietic Stem Cell Therapy
2) By Gene Therapy: In Vivo Gene Therapy, Ex Vivo Gene Therapy, Viral Vector Based Gene Therapy, Non Viral Vector Based Gene Therapy, Genome Editing Gene Therapy
3) By Pharmacological Therapy: Neuroprotective Drugs, Neurotrophic Factor Based Drugs, Anti Inflammatory Drugs, Antioxidant Drugs, Cholinesterase Inhibitors
4) By Neurostimulation Therapy: Deep Brain Stimulation, Transcranial Magnetic Stimulation, Vagus Nerve Stimulation, Spinal Cord Stimulation, Transcranial Direct Current Stimulation
5) By Other Types Of Neuroregeneration Therapy: Nanotechnology Based Therapy, Exosome Based Therapy, Biomaterial Based Therapy, Electromagnetic Field Therapy, Hyperbaric Oxygen Therapy
What Upcoming Trends Are Expected To Impact The Neuroregeneration Therapy Market Globally?
Prominent organizations active in the neuroregeneration therapy market are diverting their efforts towards the development of advanced solutions such as resorbable implants. This is done with the objective of enhancing nerve regeneration, supporting axonal growth, and ameliorating clinical outcomes in the sphere of peripheral nerve repair. Essentially, a resorbable implant is a medical apparatus that dissolves, being subsequently absorbed by the human body after serving its intended purpose, making the process of surgical removal redundant. To illustrate, Integra LifeSciences Holdings Corporation, an American biotechnology enterprise, unveiled the NeuraGen 3D Nerve Guide Matrix in March 2022. This product, specifically developed for peripheral nerve discontinuities repair, combines Integra’s bovine type 1 collagen and an innovative inner matrix with porous channels to facilitate an ideal environment for nerve healing, guiding Schwann cell migration and directing axonal growth. This breakthrough represents a major leap in peripheral nerve repair, equipping surgeons with an alternative solution for short-to-mid-gap nerve repairs. Furthermore, it is the fruit of years of concerted research and innovative partnership, aimed at enhancing patients’ functional recovery post nerve injuries.
Who Are The Top-Ranked Companies In The Neuroregeneration Therapy Market Today?
Major companies operating in the neuroregeneration therapy market are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi S.A., AstraZeneca PLC, Novartis International AG, Stryker Corporation, Biogen Inc., Synovis Life Technologies Inc., Integra LifeSciences Holdings Corporation, AxoGen Inc., Denali Therapeutics Inc., Aspen Neuroscience Inc., Neurona Therapeutics Inc., Lineage Cell Therapeutics Inc., Checkpoint Surgical Inc., Stemedica Cell Technologies Inc., Polyganics B.V., Epineuron Technologies Inc., NeuExcell Therapeutics Inc.
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/neuroregeneration-therapy-global-market-report
How Is Neuroregeneration Therapy Market Adoption Varying Across Different Regions And Sectors?
North America was the largest region in the neuroregeneration therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neuroregeneration therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27358&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model